Betaine ( DrugBank: Betaine )
2 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
201 | Angelman syndrome | 1 |
337 | Homocystinuria | 1 |
201. Angelman syndrome
Clinical trials : 25 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 22 - Drug target pathways : 20
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00348933 (ClinicalTrials.gov) | July 2006 | 3/7/2006 | Dietary Supplements for the Treatment of Angelman Syndrome | Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome | Angelman Syndrome;Nervous System Diseases | Drug: Betaine;Drug: Creatine;Drug: Metafolin;Drug: Vitamin B12 | University of California, San Diego | Baylor College of Medicine;Rady Children's Hospital, San Diego;Boston Children’s Hospital;Greenwood Genetic Center;Rare Diseases Clinical Research Network | Completed | N/A | 5 Years | All | 90 | N/A | United States |
337. Homocystinuria
Clinical trials : 16 / Drugs : 19 - (DrugBank : 7) / Drug target genes : 2 - Drug target pathways : 23
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02404337 (ClinicalTrials.gov) | July 2015 | 6/3/2015 | Betaine METABOLISM OF PATIENTS With Homocystinuria | Betaine METABOLISM OF PATIENTS With Homocystinuria | Homocystinuria | Drug: Betaine | Assistance Publique - Hôpitaux de Paris | NULL | Completed | 1 Year | 18 Years | All | 12 | Phase 2 | France |